Published in Ann Oncol on September 23, 2011
Efficacy and tolerability of anthracycline-based therapy in elderly patients with diffuse large B-cell lymphoma. Clin Lymphoma Myeloma Leuk (2014) 0.94
Treatment of diffuse large B-cell lymphoma in the elderly: regimens without anthracyclines are common and not futile. Leuk Lymphoma (2014) 0.90
Factors that influence treatment decision-making in elderly DLBCL patients: a case vignette study. Ann Hematol (2015) 0.78
Comparative effectiveness of anthracycline-containing chemotherapy in United States veterans age 80 and older with diffuse large B-cell lymphoma. J Geriatr Oncol (2015) 0.77
Actual prognosis during follow-up of survivors of B-cell non-Hodgkin lymphoma in the Netherlands. Haematologica (2013) 0.75
Variation in guideline adherence in non-Hodgkin's lymphoma care: impact of patient and hospital characteristics. BMC Cancer (2015) 0.75
Interleukin-9 promotes cell survival and drug resistance in diffuse large B-cell lymphoma. J Exp Clin Cancer Res (2016) 0.75
Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer (2013) 14.03
Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma. N Engl J Med (1995) 6.52
Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol (2007) 6.35
Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med (1999) 5.82
Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study. Diabetologia (2011) 3.52
Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer. Thorax (2004) 2.77
[Guideline 'Melanoma' (3rd revision)]. Ned Tijdschr Geneeskd (2005) 2.08
[The practice guideline: 'Treatment of tobacco dependence']. Ned Tijdschr Geneeskd (2005) 2.06
The granularity of medical narratives and its effect on the speed and completeness of information retrieval. J Am Med Inform Assoc (1998) 2.03
Risk of second primary in situ and invasive melanoma in a Dutch population-based cohort: 1989-2008. Br J Dermatol (2012) 2.03
[Surgery and referral for subsequent 131I therapy for patients with differentiated thyroid carcinoma in the south-east of the Netherlands, 1983-1996, compared to the consensus guidelines from 1987]. Ned Tijdschr Geneeskd (2002) 1.94
On the rising trends of incidence and prognosis for breast cancer patients diagnosed 1975-2004: a long-term population-based study in southeastern Netherlands. Cancer Causes Control (2007) 1.93
Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study. Eur J Cancer (2005) 1.93
Determining the cause of death in randomized screening trial(s) for prostate cancer. BJU Int (2003) 1.90
Medical narratives in electronic medical records. Int J Med Inform (1997) 1.88
Age-specific differences in the diagnostics and treatment of cancer patients aged 50 years and older in the province of Limburg, The Netherlands. Ann Oncol (1996) 1.76
Verapamil is associated with an increased risk of cancer in the elderly: the Rotterdam study. Eur J Cancer (2003) 1.70
Are patients with skin cancer at lower risk of developing colorectal or breast cancer? Am J Epidemiol (2008) 1.69
Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984-1992. Eur J Cancer (2002) 1.66
Predictions of skin cancer incidence in the Netherlands up to 2015. Br J Dermatol (2005) 1.66
Variations in treatment policies and outcome for bladder cancer in the Netherlands. Eur J Surg Oncol (2010) 1.47
Prognosis for long-term survivors of cancer. Ann Oncol (2007) 1.47
Viridans streptococci isolated from the bloodstream. Relevance of species identification. Diagn Microbiol Infect Dis (1995) 1.46
Testicular cancer in Europe and the USA: survival still rising among older patients. Ann Oncol (2012) 1.45
[The correlation of age and comorbidity with therapy and survival in cancer patients in North-Brabant and North-Limburg, 1995-2001]. Ned Tijdschr Geneeskd (2005) 1.44
Co-morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer. Br J Surg (2005) 1.44
[Trends in the incidence and death from cancer from 1989-2003 in The Netherlands]. Ned Tijdschr Geneeskd (2006) 1.42
Home care versus hospital care of patients with hematological malignancies and chemotherapy-induced cytopenia. Ann Oncol (2005) 1.41
Thrombotic and infectious complications of central venous catheters in patients with hematological malignancies. Ann Oncol (2007) 1.41
Interferon treatment of refractory idiopathic thrombocytopenic purpura (ITP) Eur J Haematol (1994) 1.39
[A comparative study of the expenditures on health research in 7 western countries in 1997 places the Netherlands at the bottom of the list]. Ned Tijdschr Geneeskd (2002) 1.39
Multidrug resistance mediated by P-glycoprotein in haematological malignancies. Neth J Med (1993) 1.38
Cancer in children and adolescents in Europe: developments over 20 years and future challenges. Eur J Cancer (2006) 1.38
Incidence, survival and prevalence of myeloid malignancies in Europe. Eur J Cancer (2012) 1.32
Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery. Gut (2005) 1.32
Rising trends in the incidence of and mortality from cutaneous melanoma in the Netherlands: a Northwest to Southeast gradient? Eur J Cancer (2003) 1.32
Lymphoedema and reduced shoulder function as indicators of quality of life after axillary lymph node dissection for invasive breast cancer. Br J Surg (2003) 1.31
Recent trends in cancer survival across Europe between 2000 and 2004: a model-based period analysis from 12 cancer registries. Eur J Cancer (2008) 1.29
Comorbidity has negligible impact on treatment and complications but influences survival in breast cancer patients. Br J Cancer (2004) 1.29
Breast cancer in elderly compared to younger patients in the Netherlands: stage at diagnosis, treatment and survival in 127,805 unselected patients. Breast Cancer Res Treat (2010) 1.27
Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems. J Clin Pathol (2002) 1.25
Development of quality indicators for diagnosis and treatment of patients with non-small cell lung cancer: a first step toward implementing a multidisciplinary, evidence-based guideline. Lung Cancer (2006) 1.22
The influence of age and co-morbidity on treatment and prognosis of ovarian cancer: a population-based study. Gynecol Oncol (2005) 1.21
MIB-1 labelling index is an independent prognostic marker in primary breast cancer. Br J Cancer (1998) 1.21
Improving outcome for patients with pancreatic cancer through centralization. Br J Surg (2011) 1.19
Impact of comorbidity on treatment and prognosis of prostate cancer patients: a population-based study. Crit Rev Oncol Hematol (2005) 1.19
Clinical epidemiology of breast cancer in the elderly. Eur J Cancer (2007) 1.17
Socioeconomic inequalities in attending the mass screening for breast cancer in the south of the Netherlands--associations with stage at diagnosis and survival. Breast Cancer Res Treat (2011) 1.16
Pneumonia due to Micrococcus spp. in a patient with acute myeloid leukaemia. Leukemia (1992) 1.15
A 50% higher prevalence of life-shortening chronic conditions among cancer patients with low socioeconomic status. Br J Cancer (2010) 1.15
Improved survival of colon cancer due to improved treatment and detection: a nationwide population-based study in The Netherlands 1989-2006. Ann Oncol (2010) 1.15
Long-term quality of life among Dutch prostate cancer survivors: results of a population-based study. Cancer (2006) 1.15
Adjuvant treatment for elderly patients with stage III colon cancer in the southern Netherlands is affected by socioeconomic status, gender, and comorbidity. Ann Oncol (2005) 1.14
Dose-dense epirubicin and paclitaxel with G-CSF: a study of decreasing intervals in metastatic breast cancer. Br J Cancer (2000) 1.11
Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer. Eur J Cancer (2005) 1.10
Treatment and survival of 38 female breast lymphomas: a population-based study with clinical and pathological reviews. Ann Hematol (2003) 1.10
Prevalence and course of fatigue in breast cancer patients receiving adjuvant chemotherapy. Ann Oncol (2004) 1.10
Better survival in patients with metastasised kidney cancer after nephrectomy: a population-based study in the Netherlands. Eur J Cancer (2011) 1.10
Elderly patients with rectal cancer have a higher risk of treatment-related complications and a poorer prognosis than younger patients: a population-based study. Eur J Cancer (2006) 1.09
Independent prognostic effect of co-morbidity in lymphoma patients: results of the population-based Eindhoven Cancer Registry. Eur J Cancer (2005) 1.08
Does sunlight prevent cancer? A systematic review. Eur J Cancer (2006) 1.07
Trends in incidence, treatment and survival of gastric adenocarcinoma between 1990 and 2007: a population-based study in the Netherlands. Eur J Cancer (2010) 1.06
Improved survival of patients with rectal cancer since 1980: a population-based study. Eur J Cancer (2003) 1.04
Impact of age and co-morbidity on surgical resection rate and survival in patients with oesophageal and gastric cancer. Br J Surg (2012) 1.04
Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction therapy of acute myeloid leukemia. J Clin Oncol (1997) 1.04
Disease-specific mortality among stage I-III colorectal cancer patients with diabetes: a large population-based analysis. Diabetologia (2012) 1.03
Scrotal cancer: incidence, survival and second primary tumours in the Netherlands since 1989. Br J Cancer (2010) 1.03
The impact of comorbidity on Health-Related Quality of Life among cancer survivors: analyses of data from the PROFILES registry. J Cancer Surviv (2013) 1.03
The prognosis of patients with local recurrence more than five years after breast conservation therapy for invasive breast carcinoma. Eur J Surg Oncol (2005) 1.02
Primary malignancy after primary female breast cancer in the South of the Netherlands, 1972-2001. Breast Cancer Res Treat (2005) 1.00
Greater influence of age than co-morbidity on primary treatment and complications of prostate cancer patients: an in-depth population-based study. Prostate Cancer Prostatic Dis (2006) 0.99
Increased risk of second malignancies after in situ breast carcinoma in a population-based registry. Br J Cancer (2006) 0.99
[Trends, causes, approach and consequences related to the skin-cancer epidemic in the Netherlands and Europe]. Ned Tijdschr Geneeskd (2006) 0.98
Survival of patients with ovarian cancer due to a mismatch repair defect. Fam Cancer (2005) 0.98
Increased health care utilisation among 10-year breast cancer survivors. Support Care Cancer (2006) 0.97
Screening caused rising incidence rates of ductal carcinoma in situ of the breast. Breast Cancer Res Treat (2008) 0.97
Trends in incidence of and mortality from cancer in The Netherlands in the period 1989-1998. Eur J Cancer (2003) 0.97
Normal hospital and low-bacterial diet in patients with cytopenia after intensive chemotherapy for hematological malignancy: a study of safety. Ann Oncol (2007) 0.96
Up-to-date survival estimates and historical trends of cutaneous malignant melanoma in the south-east of The Netherlands. Ann Oncol (2007) 0.96
Course of mental fatigue and motivation in breast cancer patients receiving adjuvant chemotherapy. Ann Oncol (2005) 0.96
Risks of second primary breast and urogenital cancer following female breast cancer in the south of The Netherlands, 1972-2001. Eur J Cancer (2005) 0.94
Lifestyle changes and reduction of colon cancer incidence in Europe: A scenario study of physical activity promotion and weight reduction. Eur J Cancer (2010) 0.94
Lymph node examination among patients with gastric cancer: variation between departments of pathology and prognostic impact of lymph node ratio. Eur J Surg Oncol (2011) 0.94
Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin-gemcitabine or carboplatin-paclitaxel: NVALT-3 a phase III study. Ann Oncol (2011) 0.93
Increasing prevalence of comorbidity in patients with colorectal cancer in the South of the Netherlands 1995-2010. Int J Cancer (2012) 0.93
Vincristine, doxorubicin and dexamethasone (VAD) administered as rapid intravenous infusion for first-line treatment in untreated multiple myeloma. Br J Haematol (1999) 0.93
Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015. J Eur Acad Dermatol Venereol (2013) 0.93